End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
30,000 KRW | +1.52% | +5.26% | +16.05% |
2023 | NeoPharm CO., LTD. Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
2019 | NeoPharm CO., LTD. announced that it has received KRW 31.970667276 billion in funding | CI |
Chart: Technical Analysis
- Stock Market
- Equities
- A092730 Stock
- Charts NeoPharm CO., LTD.